Top Life Sciences Startups in 2024

Our goal is to empower every person to realize their most confident self. RealSelf is the leading consumer destination in the $32B US medical aesthetics market. We make the experience of choosing a procedure and connecting with the right doctor easy, personal and trusted. Since 2006 our authentic reviews, unbiased ratings, and expert answers from board-certified doctors have helped tens of millions of people explore their options, from skincare to laser skin resurfacing to highly considered cosmetic surgery. Millions of people from around the world visit RealSelf each month to browse patient reviews, before and after photos, and medical experts’ answers to discover which treatments and doctors live up to their promise of being "Worth It." From skincare and emerging nonsurgical technologies to highly considered cosmetic surgeries, RealSelf makes it easy to get the insights consumers need to make smart, confident decisions and find the right doctor. With the backing of world-class investors, we’re growing RealSelf into a global business with a broad range of services. Join us and put your creative and problem-solving skills to work at realself.com/jobs.

Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Our dedication to our mission is fueling explosive growth, with both our test volume and revenue doubling year-over-year for the past four years. Our team has grown from 300 employees to more than 1,000 in just two years and we have helped hundreds of thousands of patients get the answers they need. Why medical genetics? Within each of us lies information coded in our DNA that can transform our health. Unlocking those answers to make medicine more personalized requires highly specialized, multidisciplinary collaboration. Our platform is setting the standard for the exploding medical genetics industry by harnessing the power of advanced technologies – robotics, artificial intelligence, machine learning, software engineering – and world-class genetic expertise. We provide genetic information that guides decisions for patients facing a vast array of health questions, from ultra-rare diseases and the most common cancers to starting a family. The team driving our mission thrives in a culture designed to enable innovation at scale. We are grounded in freedom with responsibility and a universal sense of urgency and ownership. Employees are empowered to speak up, try new things and make decisions that push us forward. We provide all employees with opportunities to grow and advance, supported by flexible work hours, unlimited paid time off, the ability to work anywhere for many roles and the satisfaction of doing meaningful work. Each day at Invitae means driving forward toward a new era in which everyone can have their health decisions guided by genetics.

Virgo makes it easy for physicians to record, manage, and access their endoscopy videos in the cloud. This enables physicians to use videos for research, training, quality improvement initiatives, and patient education. The Virgo platform also enables partners, including leading global pharmaceutical companies and Academic Medical Centers, to seamlessly identify, qualify and recruit the right patients to into clinical trials. Since launching in May 2018, the 100,000+ procedure videos we’ve capture — the largest data set of its kind — are powering industry-leading advancement of AL / ML in Gastrointestinal medicine.

Volta Labs was spun out of MIT in 2018 with the simple mission of building biological automation from the ground up. Volta is in the proximity of Kendall Square, known as "the most innovative square mile on the planet". Being part of the open biotech culture in Kendall Square made us realize that today’s biologists are held back by the limitations of existing automation tools. With DNA sequencing in particular, we observed that the advances in DNA readout technologies had moved further along than the advances in the upstream steps of preparing samples for sequencing (sample prep). ‍ What started out as a simple printed circuit board to manipulate colored droplets at the MIT Media Lab during co-founder Udayan Umapathi’s graduate work was quickly directed toward solving the “sample prep bottleneck”. The company raised Seed Funding from top VCs in 2019 and later that year added Will Langford as a co-founder and Head of Engineering. ‍ Since then, we have been heads down in the lab inventing and building novel fluidic and sample manipulation technologies. We take an anti-disciplinary approach to solve very hard problems and weave together instrumentation, fluidics, software, biology and chemistry. While our current focus is on sequencing sample prep, we envision a new approach where a single universal machine automates most biological workflows in genomics, proteomics and synthetic biology.

Mendel’s confounders are a physician and a computer scientist. Each dreamed of building a “Jarvis” for medicine since they were 15 years old. Mendel envisions a future where machines learn from all patients and power better decisions across the entire spectrum of healthcare.

Ultrahuman helps you improve your diet and exercise based on biomarkers. The metabolic health crisis is unarguably one of the largest healthcare crises that exists today. Metabolic disorders contribute to almost 85% of all chronic diseases in the world. By helping people understand how food and exercise affects their metabolic health, people would be able to make informed choices about what they eat and their activity levels.

Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners. Augmedix is on a mission to help clinicians and patients form a human connection by seamlessly integrating our technology at the point of care. Augmedix’s proprietary platform digitizes natural clinician-patient conversations, which are converted into comprehensive medical notes and structured data in real time. The company’s platform uses automatic speech recognition, and natural language processing, including large language models, to generate accurate and timely medical notes that are transferred into the EHR. Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout, increasing clinician efficiency and improving patient access. Through Augmedix’s proprietary platform and bi-directional communication channel, Augmedix is ideally suited to serve as the vehicle for change at the point of care. Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit augmedix.com.

Zocdoc is the tech company at the beginning of a better healthcare experience. Each month, millions of patients use Zocdoc to find in-network neighborhood doctors, instantly book appointments online, see what other real patients have to say, get reminders for upcoming appointments and preventive check-ups, fill out their paperwork online, and more. With a mission to give power to the patient, Zocdoc’s online marketplace delivers the accessible, seamless, and simple experience patients expect and deserve.

Veeva builds enterprise cloud technology that powers the biggest names in the pharmaceutical, biotech, consumer goods, chemical & cosmetics industries. Our customers make vaccines, life-saving medicines, and life-enhancing products that make a difference in everyday lives. Our technology has transformed these industries; enabling them to get critical products and services to market faster. Our core values, Do the Right Thing, Customer Success, Employee Success, and Speed, guide us as we make our customers more efficient and effective in everything they do.

We have created a revolutionary silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to our customers. We provide an innovative silicon-based DNA Synthesis Platform which enables production of high-quality synthetic DNA which is faster and more affordable than ever before. Our platform allows you to work with genes, oligo pools (with CRISPR), variant libraries, DNA data storage and NGS target enrichment.